indicated

Gain Therapeutics Achieves Remarkable Breakthrough in Parkinson’s Disease Research

Gain Therapeutics, Inc. (Nasdaq: GANX), a pioneering biotechnology company specializing in innovative allosteric small molecule therapies, has made significant strides in the fight against Parkinson's disease (PD). The Company's lead drug candidate, GT-02287, has demonstrated extraordinary potential in mitigating the effects of Parkinson's disease across two distinct preclinical models of the ailment. These findings suggest that GT-02287 has the capacity to alleviate Parkinson's disease pathology and enhance motor function. A notable highlight is the substantial reduction of plasma Neurofilament Light Chain (NfL) levels, an emerging biomarker for neurodegeneration. This advancement

Crypto Market Trends – BUSD Launched a Crypto Recovery Fund

2023-4-6 The price volatility that has been experienced in the crypto sector since 2022 has shown the need for stablecoin issuers to hedge against their cryptocurrencies to avert potential disastrous eventualities such as implosions. Still, the market has a clear memory of the impact of the Terra USD crash on the crypto market in particular and the digital sector in general. This article discusses Binance’s initiative to introduce a recovery fund for its stablecoin Binance USD (BUSD). Binance to convert the recovery fund into a few cryptocurrencies Recently, Binance announced

Paribus: Measure Twice, Cut Once.

Measure Twice, Cut Once It was with a heavy heart that we decided this week to reschedule our MVP launch to early March. It wasn’t a decision we took lightly, knowing full well that it would cause ripples of disappointment throughout our community. As many people know we’ve been working closely with auditors at Hacken to ensure that the MVP is as secure as possible. Our decision to reschedule the launch is to allow the team at Hacken to work directly with our developers next week. Chris, our security advisor